Predict your next investment

Mirxes company logo
HEALTHCARE | Biotechnology
mirxes.com

See what CB Insights has to offer

Founded Year

2016

Stage

Series C | Alive

Total Raised

$120.1M

Valuation

$0000 

Last Raised

$77M | 3 mos ago

About Mirxes

MiRXES is a privately-held life sciences company that has developed a miRNA detection technology and identified blood-borne cancer biomarkers.

Mirxes Headquarter Location

2 Tukang Innovation Grove JTC MedTech Hub, #08-01

618305,

Singapore

+65 6816 2931

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Mirxes

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Mirxes is included in 2 Expert Collections, including Cancer Liquid Biopsies.

C

Cancer Liquid Biopsies

105 items

Products/services that analyze tumor-derived biomarkers (ctDNA, CTCs, exosomes) in blood/urine/other non-invasive liquid specimens to detect cancer earlier, guide treatment, and monitor progress. *Data fields manually updated as new information becomes available.'

C

Cancer

3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Mirxes Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Mirxes Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.